메뉴 건너뛰기




Volumn 29, Issue 10, 2011, Pages 870-873

Pharmacogenetics and the immunogenicity of protein therapeutics

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT PROTEIN;

EID: 80054773955     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2002     Document Type: Letter
Times cited : (32)

References (20)
  • 8
    • 35348983887 scopus 로고    scopus 로고
    • Frazer, K.A. et al. Nature 449, 851-861 (2007
    • (2007) Nature , vol.449 , pp. 851-861
    • Frazer, K.A.1
  • 10
    • 34247330151 scopus 로고    scopus 로고
    • Viel, K.R. et al. Blood 109, 3713-3724 (2007
    • (2007) Blood , vol.109 , pp. 3713-3724
    • Viel, K.R.1
  • 11
    • 33751008103 scopus 로고    scopus 로고
    • Reding, M.T. Haemophilia 12 Suppl 6, 30-36 (2006
    • (2006) Haemophilia , vol.12 , Issue.6 , pp. 30-36
    • Reding, M.T.1
  • 12
    • 70349328358 scopus 로고    scopus 로고
    • Ettinger, R.A. et al. Blood 114, 1423-1428 (2009
    • (2009) Blood , vol.114 , pp. 1423-1428
    • Ettinger, R.A.1
  • 20
    • 84857116513 scopus 로고    scopus 로고
    • The Guideline on the Clinical Investigation of Recombinant and Human Plasma derived Factor VIII Products.
    • The Guideline on the Clinical Investigation of Recombinant and Human Plasma derived Factor VIII Products. (EMEA/CHMP/BPWP/144533). http:// www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2011/08/ WC500109692.pdf (2009).http:// www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2011/08/WC500109692.pdf
    • (2009) EMEA/CHMP/BPWP/144533


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.